GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Krystal Biotech Inc (FRA:4KB) » Definitions » Pre-Tax Income

Krystal Biotech (FRA:4KB) Pre-Tax Income : €89.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Krystal Biotech Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Krystal Biotech's pretax income for the three months ended in Dec. 2024 was €46.4 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was €89.0 Mil. Krystal Biotech's pretax margin was 53.34%.

During the past 9 years, Krystal Biotech's highest Pretax Margin was 32.82%. The lowest was 25.44%. And the median was 29.13%.


Krystal Biotech Pre-Tax Income Historical Data

The historical data trend for Krystal Biotech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krystal Biotech Pre-Tax Income Chart

Krystal Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only -26.44 -61.57 -132.14 11.83 91.07

Krystal Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.77 0.86 14.91 26.82 46.42

Competitive Comparison of Krystal Biotech's Pre-Tax Income

For the Biotechnology subindustry, Krystal Biotech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krystal Biotech's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Krystal Biotech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Krystal Biotech's Pre-Tax Income falls into.



Krystal Biotech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Krystal Biotech's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=98.551+-35.813+0+28.326+0.0010000000000048
=91.1

Krystal Biotech's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=39.517+0+0+6.906+0
=46.4

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €89.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krystal Biotech  (FRA:4KB) Pre-Tax Income Explanation

Krystal Biotech's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=46.423/87.038
=53.34%

During the past 9 years, Krystal Biotech's highest Pretax Margin was 32.82%. The lowest was 25.44%. And the median was 29.13%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krystal Biotech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Krystal Biotech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Krystal Biotech Business Description

Traded in Other Exchanges
Address
2100 Wharton Street, Suite 701, Pittsburgh, PA, USA, 15203
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Krystal Biotech Headlines

No Headlines